To screen or nor to screen: the prostate cancer dilemma

The European Randomized Study of Screening for Prostate (ERSPC) has updated their previous seminal report on prostate cancer mortality comparing screened men to controls. Now with 13 years follow-up, the rate ratio of prostate cancer mortality was 0.79 favoring the screened population. The authors c...

Full description

Bibliographic Details
Main Authors: Nelson N Stone, E David Crawford
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-02-01
Series:Asian Journal of Andrology
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=1;spage=44;epage=45;aulast=Stone